{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:57:35Z","timestamp":1776185855740,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"W1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["716063"],"award-info":[{"award-number":["716063"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["824087"],"award-info":[{"award-number":["824087"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academy of Finland Research Fellow","award":["317680"],"award-info":[{"award-number":["317680"]}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201706740080"],"award-info":[{"award-number":["201706740080"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finland's EDUFI Fellowship","award":["TM-18-10928"],"award-info":[{"award-number":["TM-18-10928"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug combination therapy has the potential to enhance efficacy, reduce dose-dependent toxicity and prevent the emergence of drug resistance. However, discovery of synergistic and effective drug combinations has been a laborious and often serendipitous process. In recent years, identification of combination therapies has been accelerated due to the advances in high-throughput drug screening, but informatics approaches for systems-level data management and analysis are needed. To contribute toward this goal, we created an open-access data portal called DrugComb (https:\/\/drugcomb.fimm.fi) where the results of drug combination screening studies are accumulated, standardized and harmonized. Through the data portal, we provided a web server to analyze and visualize users\u2019 own drug combination screening data. The users can also effectively participate a crowdsourcing data curation effect by depositing their data at DrugComb. To initiate the data repository, we collected 437 932 drug combinations tested on a variety of cancer cell lines. We showed that linear regression approaches, when considering chemical fingerprints as predictors, have the potential to achieve high accuracy of predicting the sensitivity of drug combinations. All the data and informatics tools are freely available in DrugComb to enable a more efficient utilization of data resources for future drug combination discovery.<\/jats:p>","DOI":"10.1093\/nar\/gkz337","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T07:28:10Z","timestamp":1556263690000},"page":"W43-W51","source":"Crossref","is-referenced-by-count":240,"title":["DrugComb: an integrative cancer drug combination data portal"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-110X","authenticated-orcid":false,"given":"Bulat","family":"Zagidullin","sequence":"first","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Jehad","family":"Aldahdooh","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Shuyu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Yinyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Joseph","family":"Saad","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Alina","family":"Malyutina","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Mohieddin","family":"Jafari","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"given":"Ziaurrehman","family":"Tanoli","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-9191","authenticated-orcid":false,"given":"Alberto","family":"Pessia","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-7710","authenticated-orcid":false,"given":"Jing","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland, Helsinki Life Science Institute, University of Helsinki, Finland"},{"name":"Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland"}]}],"member":"286","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"2019062808130277500_B1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2019062808130277500_B2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2019062808130277500_B3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(13)62226-6","article-title":"Rethinking the war on cancer","volume":"383","author":"Hanahan","year":"2014","journal-title":"Lancet"},{"key":"2019062808130277500_B4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Crystal","year":"2014","journal-title":"Science"},{"key":"2019062808130277500_B5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/13816128113199990470","article-title":"Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles","volume":"20","author":"Tang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"2019062808130277500_B6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-050913-022545","article-title":"Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors","volume":"66","author":"Lord","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"2019062808130277500_B7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"2019062808130277500_B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-1-4939-7154-1_30","article-title":"Informatics approaches for predicting, understanding, and testing cancer drug combinations","volume":"1636","author":"Tang","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"2019062808130277500_B9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/2159-8290.CD-16-0440","article-title":"High-throughput testing of novel-novel combination therapies for cancer: an idea whose time has come","volume":"6","author":"Scarlett","year":"2016","journal-title":"Cancer Discov."},{"key":"2019062808130277500_B10","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B11","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B12","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2019062808130277500_B14","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B15","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The Catalogue of Somatic Mutations in Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a Large-Scale Small-Molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov."},{"key":"2019062808130277500_B17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2017.01.005","article-title":"Characterization of human cancer cell lines by Reverse-phase protein arrays","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"2019062808130277500_B18","doi-asserted-by":"crossref","first-page":"160018","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR guiding principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci. Data"},{"key":"2019062808130277500_B19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrg2825","article-title":"Tackling the widespread and critical impact of batch effects in high-throughput data","volume":"11","author":"Leek","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"2019062808130277500_B20","first-page":"93","article-title":"What is synergy","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"2019062808130277500_B21","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittel-Forschung"},{"key":"2019062808130277500_B22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex Dose-Response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2019062808130277500_B23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"2019062808130277500_B24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphar.2015.00181","article-title":"What is synergy? The saariselka agreement revisited","volume":"6","author":"Tang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"2019062808130277500_B25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4939-7493-1_17","article-title":"Methods for High-throughput drug combination screening and synergy scoring","volume":"1711","author":"He","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"2019062808130277500_B26","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The national cancer institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity","volume":"77","author":"Holbeck","year":"2017","journal-title":"Cancer Res."},{"key":"2019062808130277500_B27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"2019062808130277500_B28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cels.2017.05.002","article-title":"Systematic quantification of population cell death kinetics in mammalian cells","volume":"4","author":"Forcina","year":"2017","journal-title":"Cell Syst."},{"key":"2019062808130277500_B29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nchembio.2382","article-title":"A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor","volume":"13","author":"Licciardello","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"2019062808130277500_B30","doi-asserted-by":"crossref","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-Response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"2019062808130277500_B31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.3834","article-title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions","volume":"35","author":"Han","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"2019062808130277500_B32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nbt.4062","article-title":"Dual gene activation and knockout screen reveals directional dependencies in genetic networks","volume":"36","author":"Boettcher","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"2019062808130277500_B33","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B34","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gky962","article-title":"New approach for understanding genome variations in KEGG","volume":"47","author":"Kanehisa","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2016.04.007","article-title":"A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice","volume":"163","author":"Chisamore","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"2019062808130277500_B36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","article-title":"Drug target commons: A community effort to build a consensus knowledge base for Drug-Target interactions","volume":"25","author":"Tang","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"2019062808130277500_B37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","article-title":"The cellosaurus, a cell-line knowledge resource","volume":"29","author":"Bairoch","year":"2018","journal-title":"J. Biomol. Tech."},{"key":"2019062808130277500_B38","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-14-0725","article-title":"Enhancing reproducibility in cancer drug screening: how do we move forward","volume":"74","author":"Hatzis","year":"2014","journal-title":"Cancer Res."},{"key":"2019062808130277500_B39","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/acs.jmedchem.7b00204","article-title":"Prediction of antibiotic interactions using descriptors derived from molecular structure","volume":"60","author":"Mason","year":"2017","journal-title":"J. Med. Chem."},{"key":"2019062808130277500_B40","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with Deep Learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"2019062808130277500_B41","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose\u2013response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"key":"2019062808130277500_B42","doi-asserted-by":"crossref","first-page":"W46","DOI":"10.1093\/nar\/gku433","article-title":"DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome","volume":"42","author":"Luo","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2019062808130277500_B43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"2019062808130277500_B44","doi-asserted-by":"crossref","first-page":"D923","DOI":"10.1093\/nar\/gky872","article-title":"Cell model Passports\u2014a hub for clinical, genetic and functional datasets of preclinical cancer models","volume":"47","author":"van\u00a0der\u00a0Meer","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/advance-article-pdf\/doi\/10.1093\/nar\/gkz337\/28568084\/gkz337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/47\/W1\/W43\/28880110\/gkz337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T02:27:59Z","timestamp":1574562479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/47\/W1\/W43\/5486743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":44,"journal-issue":{"issue":"W1","published-online":{"date-parts":[[2019,5,8]]},"published-print":{"date-parts":[[2019,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkz337","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/560227","asserted-by":"object"}]},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,2]]},"published":{"date-parts":[[2019,5,8]]}}}